IL30206A - Process for inactivating microorganisms and/or their antigens - Google Patents

Process for inactivating microorganisms and/or their antigens

Info

Publication number
IL30206A
IL30206A IL30206A IL3020668A IL30206A IL 30206 A IL30206 A IL 30206A IL 30206 A IL30206 A IL 30206A IL 3020668 A IL3020668 A IL 3020668A IL 30206 A IL30206 A IL 30206A
Authority
IL
Israel
Prior art keywords
vaccine
inactivation
antigens
inactivated
days
Prior art date
Application number
IL30206A
Other languages
English (en)
Other versions
IL30206A0 (en
Original Assignee
Behringwerke Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke Ag filed Critical Behringwerke Ag
Publication of IL30206A0 publication Critical patent/IL30206A0/xx
Publication of IL30206A publication Critical patent/IL30206A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0241—Mollicutes, e.g. Mycoplasma, Erysipelothrix
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/08—Clostridium, e.g. Clostridium tetani
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/205—Rhabdoviridae, e.g. rabies virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/20011—Rhabdoviridae
    • C12N2760/20111—Lyssavirus, e.g. rabies virus
    • C12N2760/20134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/20011—Rhabdoviridae
    • C12N2760/20111—Lyssavirus, e.g. rabies virus
    • C12N2760/20161—Methods of inactivation or attenuation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
IL30206A 1967-06-22 1968-06-19 Process for inactivating microorganisms and/or their antigens IL30206A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE1617350A DE1617350C3 (de) 1967-06-22 1967-06-22 Verfahren zur Inaktivierung von biologischem Material

Publications (2)

Publication Number Publication Date
IL30206A0 IL30206A0 (en) 1968-08-22
IL30206A true IL30206A (en) 1972-05-30

Family

ID=6986788

Family Applications (1)

Application Number Title Priority Date Filing Date
IL30206A IL30206A (en) 1967-06-22 1968-06-19 Process for inactivating microorganisms and/or their antigens

Country Status (9)

Country Link
JP (1) JPS494932B1 (de)
AT (1) AT279041B (de)
BE (1) BE717053A (de)
BR (1) BR6800054D0 (de)
CH (1) CH562612A5 (de)
DE (1) DE1617350C3 (de)
FR (2) FR1588829A (de)
IL (1) IL30206A (de)
LU (1) LU56297A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2748132A1 (de) * 1977-10-27 1979-05-03 Behringwerke Ag Stabilisator fuer polysaccharid
US4456590B2 (en) * 1981-11-02 1989-05-30 Heat treatment of lyphilized blood clotting factor viii concentrate
JPS6013718A (ja) * 1983-07-05 1985-01-24 Chemo Sero Therapeut Res Inst Ｂ型肝炎ワクチン
JPS6122331U (ja) * 1984-07-16 1986-02-08 マルコン電子株式会社 回転機用コンデンサ
JPS6286707A (ja) * 1985-10-02 1987-04-21 アテシ 高電圧高エネルギ−密度コンデンサ
FR2814957B1 (fr) * 2000-10-06 2002-12-20 Aventis Pasteur Composition vaccinale et procede de stabilisation

Also Published As

Publication number Publication date
DE1617350B2 (de) 1979-01-11
AT279041B (de) 1970-02-25
DE1617350A1 (de) 1971-03-25
LU56297A1 (de) 1970-01-15
IL30206A0 (en) 1968-08-22
CH562612A5 (en) 1975-06-13
FR8086M (de) 1970-07-20
DE1617350C3 (de) 1979-09-06
BE717053A (de) 1968-12-24
JPS494932B1 (de) 1974-02-04
BR6800054D0 (pt) 1973-02-13
FR1588829A (de) 1970-03-16

Similar Documents

Publication Publication Date Title
IE48402B1 (en) Pasteurellosis vaccines
US10632188B2 (en) Compositions containing ambient-temperature stable, inactivated but therapeutically active biopharmaceuticals and methods for formulation thereof
EP3024487A1 (de) Verfahren zur inaktivierung von viren unter verwendung von elektronenstrahlen
US4292307A (en) Vaccine and method for prophylaxis and treatment of clostridioses of animals and poultry
KR100447297B1 (ko) 개량된불활성백신
IL30206A (en) Process for inactivating microorganisms and/or their antigens
US3859168A (en) Process of inactivating rabies virus
JPH05508407A (ja) パスツレラ・ムルトシダのトキソイドワクチン
IL30168A (en) Antigen-free vaccine and process for preparing it
CN110507819B (zh) 青蒿琥酯作为免疫佐剂在制备狂犬病疫苗中的应用
JP3812814B2 (ja) 動物用多価オイルアジュバントワクチン
TW546146B (en) Erysipelothrix rhusiopathiae antigens and vaccine compositions
PT1387693E (pt) Vacina de micoplasma inactivado por saponina
RU2259214C1 (ru) Способ получения вакцины оспенной инактивированной сухой "оспавир"
US11213579B2 (en) Vaccines with enhanced immunogenicity, low allergenicity and reactogenicity
AT410172B (de) Verfahren zur herstellung einer vakzineformulierung
DD298884A5 (de) Impfstoffe gegen virale antigene und verfahren zu ihrer herstellung
Cooper et al. Laboratory studies on the vaccination of mice and turkeys with an Erysipelothrix rhusiopathiae vaccine
RU2134590C1 (ru) Способ изготовления инактивированной вакцины против бешенства животных
RU2344832C1 (ru) Вакцинный препарат против колибактериоза
CN111603566A (zh) 一种靶向呼吸道黏膜的递呈载体复合物及应用
Moges et al. Veterinary Vaccines: Unlocking the Power of Immunization for Livestock Health—A Review
Mahboob et al. Preparation and evaluation of Newcastle disease oil emulsion vaccine at hydrophile-lipophile balance 7.0 using Mukteswar strain
RU2285539C2 (ru) Молекулярная бивалентная вакцина для профилактики бруцеллеза и диарей, вызванных энтеропатогенными бактериями
EA040473B1 (ru) Вакцина с повышенной иммуногенностью и низкими аллергенностью и реактогенностью